Toft Robin's Insider Trades & SAST Disclosures
Toft Robin's most recent trade in T2 Biosystems Inc was a trade of 25,000 Restricted Stock Units done . Disclosure was reported to the exchange on Nov. 4, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Toft Robin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| T2 Biosystems Inc | Robin Toft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Toft Robin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 6,369 | 6,369 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2023 | 454 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2023 | 454 | 3,472 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Robin Toft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2022 | 115,000 | 115,000 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2022 | 22,727 | 150,936 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2022 | 22,727 | 22,727 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 73,224 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 73,224 | 128,209 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 32,258 | 54,985 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 32,258 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 22,727 | 22,727 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Robin Toft | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 22,727 | 45,454 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 73,224 | 73,224 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 32,258 | 32,258 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Robin Toft | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 68,181 | 68,181 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges